Recor Medical announced that the FDA approved its Paradise ultrasound renal denervation (RDN) system for treating hypertension.
The first U.S. commercial cases have been completed with the Abbott (NYSE: ABT)+
Aveir dual-chamber leadless pacemaker technology.
An advanced closed-loop anesthesia delivery system that monitors brain state to tailor propofol dose and achieve exactly the desired level of unconsciousness could reduce post-op side effects.
Johnson & Johnson MedTech’s (NYSE: JNJ)+
Ethicon unit today debuted an AI-powered laparoscopic surgical simulation platform.
Scores on a quality-of-life scale improved and use of antiarrhythmic drugs fell after people underwent treatment with the device.
A cyberattack group known as BlackCat is threatening to release Henry Schein (Nasdaq: HSIC)+
data unless the medical device manufacturer and distributor pays a ransom.
An interim analysis of Penumbra’s Indigo aspiration system met its primary safety and efficacy criteria, according to data shared at the Vascular Interventional Advances Conference.
As little as 1% reduction in deep sleep per year for people over 60 years of age translates into a 27% increased risk of dementia, according to a study which suggests that enhancing or maintaining deep sleep, also known as slow wave sleep, in older years could stave off dementia.